Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Nieuwe afweerreactie tegen malariaparasiet ontdekt
jun 2019 | Parasitaire infecties, Vaccinatie